Coca-Cola (KO) is switching up what shoppers will likely see in the soda aisle as GLP-1 drugs and other wellness efforts continue to reshape everyday buying habits.
Instead of betting on a specific consumer type, the beverage giant is broadening its range in several directions at once.
New products are coming across Coke, Powerade, Topo Chico, Fairlife, and other brands, as the company tests out zero-sugar drinks with added prebiotic fiber in select U.S. markets.
For consumers, that means the choice is becoming less binary. Coke is still leaning into fun, familiar refreshment, but it is increasingly pairing that with lower-sugar, protein-rich, and functional options designed for people who are rethinking what they drink.
That’s also where the GLP-1 backdrop becomes important.
These drugs are reinforcing demand for smaller indulgences and more nutritionally purposeful products. Coca-Cola’s challenge now is whether one portfolio can convincingly satisfy both appetites.
Coca-Cola is widening its bet beyond traditional soda
Coca-Cola is rolling out a broad wave of new drinks for 2027, indicating that it’s looking to now compete for both indulgent soda purchases and the growing demand for more functional beverages.
The company plans new products across Coca-Cola, Powerade, Mr. Pibb, Topo Chico, and Fairlife, with launches beginning next year, according to CBS News. Coca-Cola Cherry Lime is due in February, while Coca-Cola Strawberry Float is expected in the summer. Both will come in regular and zero-sugar versions.
Simultaneously, the popular soda brand is looking to test out a strategy alongside these new flavor launches.
Coca-Cola is also testing prebiotic versions of Coca-Cola Zero Sugar, Sprite Zero Sugar, and Fresca in parts of New York, New Jersey, and Pennsylvania, giving the company a way to probe consumer interest in functional soda without abandoning its biggest brands.
Elsewhere in the portfolio, Powerade is adding new zero-sugar options, Topo Chico is expanding its fruit-flavored lineup, and Fairlife’s Core Power protein shakes are getting their first new flavors in nearly a decade.
Taken collectively, I feel Coca-Cola is trying to stretch across two consumer moods at once: familiar treats and more health-conscious, function-led choices.
Coca-Cola is expanding its 2027 drinks lineup as consumer habits keep shifting.
GLP-1s are changing the beverage mix Coke now has to defend
Coca-Cola hasn’t claimed that its new drinks, especially the prebiotic ones, were created due to the ongoing GLP-1 (weight-loss drugs) trend, but the strategic overlap is hard to miss.
Former CEO James Quincey said during Coca-Cola’s Q3 2025 earnings call that the company’s own data showed people using GLP-1s tend to drink less full-sugar soda.
More Retail:
- Home Depot is making a big bet on cautious consumers
- Another state just banned a controversial retail pricing practice
- JPMorgan just flagged a slow-build food crisis
“Clearly, we can see some very emerging conclusions. They tend to drink less full sugar soft drinks, but they tend to drink more diet soft drinks, also hydration, more coffee, and as you say, a big shift towards protein drinks.”
So Coke’s latest pipeline, which leans heavily into those same categories, including prebiotic zero-sugar soda, zero-sugar sports drinks, and expanded Fairlife protein offerings, makes a lot of sense.
Moreover, the shift is no longer niche.
Reuters reported that roughly one in five U.S. households now includes at least one GLP-1 user, prompting major food and beverage companies to redirect product development toward higher-protein, higher-fiber, and lower-calorie formats. Coca-Cola, in particular, has been increasing capacity for its Fairlife protein business.
There is also evidence that the broader sugar market is feeling the effects of the change. U.S. sugar consumption fell 4.4% over the past two years, with US News citing rising GLP-1 use alongside soft-drink taxes as key pressures.
I see Coke’s prebiotic push as an offensive move, not a rescue plan
I feel that Coca-Cola’s prebiotic test matters a lot more than the flavor launches, as it pushes “better-for-you” functionality directly into brands consumers already know.
Coke entered the category with Simply Pop in 2025, but testing prebiotic versions of Coke Zero, Sprite Zero, and Fresca moves the idea from a niche label into its mass-market portfolio.
That also puts Coke into a fight that Pepsi has already escalated.
Pepsi launched Pepsi Prebiotic Cola nationwide in February 2026 with 3 grams of prebiotic fiber, after agreeing to buy Poppi for $1.95 billion.
Poppi retail sales had surged 122% year over year in the 12 weeks through Feb. 22, 2025, Reuters reported. To me, that is the clearest sign prebiotic soda has graduated from startup curiosity to a serious battleground.
That said, I would not frame Coca-Cola as scrambling. Its Q2 2026 results were robust, to say the least, with global unit-case volume rising 5%, revenue increasing 7%, and Coca-Cola Zero Sugar volume jumping 16%.
The company also said innovation contributed to volume growth. That makes this rollout look offensive rather than remedial.
What I find most interesting is the consumer risk. Reddit reactions suggest that people remain enthusiastic about familiar Coke flavors such as cherry and lime, while creamier “float” concepts have produced much more divided responses.
The same tension appears in prebiotic soda, where consumers may like the health proposition but still complain about taste, aftertaste, or digestive effects.
Those anecdotes are not representative research, but I think they expose Coke’s real challenge: Fiber alone will not win the shelf.
Coke has to make functional soda taste familiar enough that consumers buy it as a drink first and a wellness product second.
Related: Oprah-backed chain closes 12 restaurants for good after filing Chapter 11
